Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

A new compound shows promise as a topical treatment for hair loss.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Plasmalogens activate a channel in cells that may stimulate hair growth.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.

Phosphatidic acid may promote hair growth like minoxidil.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

Nanospanlastics are effective in targeted drug delivery for chronic diseases, improving skin conditions, treating hair loss, and increasing drug absorption.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.

Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.

Surface-modified nanoparticles mainly use non-follicular pathways to enhance skin permeation of ibuprofen and could improve treatment for inflammatory skin diseases.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Minoxidil activates hair growth by being sulfated by P-PST in the human liver.

Polysulfonic acid mucopolysaccharide can reduce skin scarring.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

TSPO might help treat anxiety and depression.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

New compounds show promise as nonsteroidal treatments for hair loss.

The diphosphonate was the most effective at preventing calcification in rats.

Lipid-based nanocosmeceuticals improve skin therapy by enhancing ingredient delivery and effectiveness for anti-aging and skin disorders.

Inhibiting SFRP1 may help treat hair loss.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.